Clopidogrel
- Product NDC
- 68788-6324
- 11-digit product format
- 687886324
- Labeler code
- 68788
- Product ID
- 68788-6324_0db40f3a-c217-4f8f-8618-0ffaa03ce4a5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clopidogrel
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA202928
- Marketing category
- ANDA
- Marketing start
- 2016-10-18
- Marketing end
- 0000-00-00
- Substance
- CLOPIDOGREL BISULFATE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68788-6324-3 | 2020-11-10 | C162847 | 48780-1 | 9d75b9d0-d4ef-f424-e053-dadaa90a57ce | 761457ae-f8a0-45ac-9310-8b38fa4485b7 |
| 68788-6324-6 | 2020-11-10 | C162847 | 48780-1 | 9d75b9d0-d4ef-f424-e053-dadaa90a57ce | 761457ae-f8a0-45ac-9310-8b38fa4485b7 |
| 68788-6324-9 | 2020-11-10 | C162847 | 48780-1 | 9d75b9d0-d4ef-f424-e053-dadaa90a57ce | 761457ae-f8a0-45ac-9310-8b38fa4485b7 |
| 68788-6324-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d4ef-f424-e053-dadaa90a57ce | 761457ae-f8a0-45ac-9310-8b38fa4485b7 |
| 68788-6324-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d4ef-f424-e053-dadaa90a57ce | 761457ae-f8a0-45ac-9310-8b38fa4485b7 |
| 68788-6324-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d4ef-f424-e053-dadaa90a57ce | 761457ae-f8a0-45ac-9310-8b38fa4485b7 |